Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand

Pediatric Infectious Disease Journal

Volumn 26, Issue 10, 2007, Pages 953-956

  Puthanakit, Thanyawee ^a   Aurpibul, Linda ^a   Oberdorfer, Peninnah ^b   Akarathum, Noppadon ^c   Kanjanavanit, Suparat ^c   Wannarit, Pornphun ^c   Sirisanthana, Thira ^a   Sirisanthana, Virat ^a,b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

HAART in children; HIV; NNRTI based HAART; Resource limited settings; Thailand

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EFAVIRENZ PLUS LAMIVUDINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THAILAND; UNSPECIFIED SIDE EFFECT; VIROLOGY;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HUMANS; RNA, VIRAL; THAILAND; TREATMENT OUTCOME;

EID: 34848919230     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e318125720a     Document Type: Article

References (14)

1. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS. 2004;18:1905-1913.
2. Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment program for HIV-infected children and their infected parents. S Afr Med J. 2004;94:643-646.
3. Kline MW, Matusa RF, Copaciu L, et al. Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania. Pediatr Infect Dis J. 2004;23:695-700.
4. O'Brien DP, Sauvageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-1960.
5. Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years. Arch Intern Med. 2003;163:2187-2195.
6. Walker SA, Doerholt K, Sharland M, Gibb DM. Response to highly active antiretroviral therapy varies with age: The UK and Ireland Collaborative HIV Paediatric study. AIDS. 2004;18:1915-1924.
7. Soh C, Oleske J, Brady MT, et al. Long-term effects of combination therapy including protease inhibitors on CD4 T cell recovery in HIV-1 infected children and adolescents. Lancet. 2003;362:2045-2051.
8. Resino S, Resino R, Micheloud D, et al. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Clin Infect Dis. 2006;42:862-869.
9. van Rossum AM, Scherpbier HJ, van Lochem EG, et al. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status. AIDS. 2001;15:2267-2275.
10. Puthanakit T, Oberdorfer A, Akaratum N, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's national access to antiretroviral program. Clin Infect Dis. 2005;41:100-107.
11. World Health Organization (WHO). Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach - 2006 revision. Geneva, Switzerland: WHO; 2006. Available at: http://www.who.int/hiv/pub/guidelines/art/en/index.html Accessed November 9, 2006.
12. Anabwani GM, Lowenthal E, Marpe M, et al. Long term response to highly active antiretroviral therapy among treatment naïve children in Botswana. In: XVI International AIDS Conference; August 13-18, 2006; Toronto, Canada. Abstract MOPE 0261.
13. Coetzee D, Hilderbrand K, Boulle A, Saranchuk P, Rabie H, Goemaere E. Pediatric outcomes after 3 years in a primary care setting in South Africa. In: XVI International AIDS Conference; August 13-18, 2006; Toronto, Canada. Abstract MOPE 0223.
14. van Leth F, Phanuphak P, Ruxrungtham K, et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: A randomized open-label trial, the 2NN study. Lancet. 2004;363:1253-1263.